Ming-Chia Lin and Li-Min Sun contributed equally to this work.
Does use of tetracyclic antidepressant—mirtazapine reduce cancer risk in depression patients?
Version of Record online: 20 SEP 2013
Copyright © 2013 John Wiley & Sons, Ltd.
Pharmacoepidemiology and Drug Safety
Volume 22, Issue 12, pages 1292–1297, December 2013
How to Cite
Sun, L.-M., Lin, M.-C., Liang, J.-A., Chang, Y.-J., Chang, S.-N., Sung, F.-C., Muo, C.-H. and Kao, C.-H. (2013), Does use of tetracyclic antidepressant—mirtazapine reduce cancer risk in depression patients?. Pharmacoepidem. Drug Safe., 22: 1292–1297. doi: 10.1002/pds.3523
- Issue online: 28 NOV 2013
- Version of Record online: 20 SEP 2013
- Manuscript Accepted: 25 AUG 2013
- Manuscript Revised: 9 JUL 2013
- Manuscript Received: 19 SEP 2012
- nested case-control study;
We conducted a nested case-control study to evaluate the association between risk of cancer and mirtazapine use in depression patients in Taiwan.
We obtained data from the Taiwan National Health Insurance Research Database to conduct a population-based nested case-control study. The study cohort included 16 897 patients diagnosed with depression between January 1, 2000 and December 31, 2008. We identified 530 cancer patients as the study group and matched 4 non-cancer subjects with each cancer patient by incident density, age, and sex. Odds ratios and 95% confidence intervals were estimated using multivariate conditional logistic regression analysis.
Use of mirtazapine for depression did not have significant effect on overall cancer incidence (odds ratio: 1.03, 95% confidence interval: 0.72–1.48). Further analysis of annual mirtazapine dosages and the duration of mirtazapine use revealed no significant effect on cancer risk.
The findings of this population-based nested case-control study suggest that mirtazapine use may not provide a tumor suppression effect in humans such as that seen in the animal model. Future large-scale and in-depth investigations in this area are warranted. Copyright © 2013 John Wiley & Sons, Ltd.